The impact of pelvic nodal radiotherapy on hematologic toxicity: A systematic review with focus on leukopenia, lymphopenia and future perspectives in prostate cancer …
GC Iorio, BO Spieler, U Ricardi, A Dal Pra - Critical reviews in oncology …, 2021 - Elsevier
Introduction Hematologic toxicity (HT), particularly leukopenia, is a common side-effect of
oncologic treatments for pelvic malignancies. Pelvic nodal radiotherapy (PNRT) has been …
oncologic treatments for pelvic malignancies. Pelvic nodal radiotherapy (PNRT) has been …
Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study
Background In patients with squamous cell carcinoma of the anus (SCCA), lymph node
positivity (LNP) indicates poor prognosis for survival and is central to radiotherapy planning …
positivity (LNP) indicates poor prognosis for survival and is central to radiotherapy planning …
Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC)
Abstract Aim Six Phase III randomized trials have determined the effectiveness of
chemoradiotherapy as primary treatment for anal squamous cell carcinoma (ASCC), but …
chemoradiotherapy as primary treatment for anal squamous cell carcinoma (ASCC), but …
Chemoradiation‐Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal
G Lee, DW Kim, V Muralidhar, D Mitra… - The …, 2020 - academic.oup.com
Background Although treatment‐related lymphopenia (TRL) is common and associated with
poorer survival in multiple solid malignancies, few data exist for anal cancer. We evaluated …
poorer survival in multiple solid malignancies, few data exist for anal cancer. We evaluated …
State of the art treatment for stage I to III anal squamous cell carcinoma: A systematic review and meta-analysis
RN Werner, M Gaskins, GA Valle, V Budach… - Radiotherapy and …, 2021 - Elsevier
Background and purpose This systematic review summarised and critically appraised
evidence on the efficacy and safety of interventions for anal cancer to support the panel of …
evidence on the efficacy and safety of interventions for anal cancer to support the panel of …
Advances in the management of anal cancer
DR Julie, KA Goodman - Current oncology reports, 2016 - Springer
Although anal squamous cell carcinoma (ASCC) is an uncommon malignancy, its incidence
has been increasing markedly in recent decades due to its association with human …
has been increasing markedly in recent decades due to its association with human …
[HTML][HTML] 18F-FDG PET predicts hematologic toxicity in patients with locally advanced anal cancer treated with chemoradiation
JM David, Y Yue, K Blas, A Hendifar… - Advances in Radiation …, 2019 - Elsevier
Purpose Hematologic toxicity (HT) during chemoradiation therapy (CRT) for anal cancer can
lead to treatment breaks that compromise efficacy. We hypothesized that CRT-induced HT …
lead to treatment breaks that compromise efficacy. We hypothesized that CRT-induced HT …
Evolution and management of treatment-related toxicity in anal cancer
EB Ludmir, LA Kachnic… - Surgical Oncology Clinics, 2017 - surgonc.theclinics.com
Anal cancer is an uncommon malignancy whose incidence has been rising over the past
several decades. 1 In 2016, it is expected that more than 8000 new cases of anal cancer will …
several decades. 1 In 2016, it is expected that more than 8000 new cases of anal cancer will …
PET-CT guided SIB-IMRT combined with concurrent 5-FU/MMC for the treatment of anal cancer
M Zimmermann, J Beer, S Bodis, R von Moos… - Acta …, 2017 - Taylor & Francis
Background: To evaluate local control (LC), survival and toxicity in anal cancer patients
treated with intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy at a …
treated with intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy at a …
Chemoradiation for anal cancer: clinical outcomes and strategies to optimize the therapeutic ratio according to HPV status
WT Turchan, SL Liauw - Seminars in Radiation Oncology, 2021 - Elsevier
The incidence of anal cancer in the United States has increased in recent years, primarily
related to the increasing incidence of HPV-associated anal squamous cell carcinoma, which …
related to the increasing incidence of HPV-associated anal squamous cell carcinoma, which …